OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
15
Results
Show all
Save search
Copy query
Show results for
Unknown
(15)
Publication Date
Release Date
2021
(4)
2024
(2)
2023
(2)
2022
(2)
2020
(2)
2026
(1)
2025
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Precision Medicine in Childhood Cancer: The Influence of Genetic Polymorphisms on Vincristine-Induced Peripheral Neuropathy.
Not available
S-EPMC11354794
|
biostudies-literature
Cite
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study.
Not available
S-EPMC7906623
|
biostudies-literature
Cite
Real-world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyurea.
Not available
S-EPMC9324831
|
biostudies-literature
Cite
The Cantabria Cohort, a protocol for a population-based cohort in northern Spain.
Not available
S-EPMC10698930
|
biostudies-literature
Cite
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain.
Not available
S-EPMC7399713
|
biostudies-literature
Cite
Neonatal Infection Due to SARS-CoV-2: An Epidemiological Study in Spain.
Not available
S-EPMC7644848
|
biostudies-literature
Cite
Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis.
Not available
S-EPMC7695946
|
biostudies-literature
Cite
Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study.
Not available
S-EPMC12006532
|
biostudies-literature
Cite
Allergy and acute leukaemia in children with Down syndrome: a population study. Report from the Mexican inter-institutional group for the identification of the causes of childhood leukaemia.
Not available
S-EPMC3681010
|
biostudies-literature
Cite
Quizartinib for Newly Diagnosed <i>FLT3</i>-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.
Not available
S-EPMC12736402
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets